Quantcast

Latest autoimmune diseases Stories

2014-07-30 23:07:26

ResearchMoz.us include new market research report "China Diagnostic Reagent Industry Report, 2013-2016" to its huge collection of research reports. Complete Report - http://www.researchmoz.us/china-diagnostic-reagent-industry-report-2013-2016-report.html. Albany, NewYork (PRWEB) July 30, 2014 With the accelerated aging of the Chinese population, the increase of personal health expenditure as well as the improved medical care facilities and government health care system, China...

2014-07-30 04:21:20

CAMBRIDGE, Mass. and HERZLIYA PITUACH, Israel, July 30, 2014 /PRNewswire/ -- Immune Pharmaceuticals Inc. (OTCQX and NASDAQ OMX First North Premier, Stockholm: "IMNP."; "Immune" or "the Company") announces today that it has initiated the screening of patients for a Phase II proof of concept clinical trial exploring the safety and efficacy of bertilimumab in the treatment of moderate to severe bullous pemphigoid. This open-label trial will enroll 10-15 patients who will receive two...

2014-07-29 16:26:15

Researchers Look to Target Gut Microbiome for Treatment and Prevention of Crohn's Disease and Ulcerative Colitis NEW YORK, July 29, 2014 /PRNewswire/ -- Early findings from a major research initiative of the Crohn's & Colitis Foundation of America (CCFA) suggest that specific bacteria play a central role in Crohn's disease and ulcerative colitis (UC), also known as inflammatory bowel diseases (IBD). The evidence raises the possibility of developing new treatments to target the...

2014-07-24 04:21:22

NEW YORK, July 24, 2014 /PRNewswire/ -- Lyfebulb, the International Pemphigus Pemphigoid Foundation (IPPF) and Immune Pharmaceuticals Inc. (OTCQX and NASDAQ OMX First North Premier, Stockholm: "IMNP."; "Immune" or "the Company"), announced a collaboration to increase awareness of unmet needs in treating bullous pemphigoid last night at an event attended by more than sixty patients, physicians, scientists and other interested parties. Lyfebulb is a health and wellness company dedicated...

2014-07-23 08:27:58

What Will Your Challenge Be? NEW YORK, July 23, 2014 /PRNewswire/ -- The Crohn's & Colitis Foundation of America's endurance training and fundraising program, Team Challenge, is thrilled to unveil its upcoming race portfolio with 11 great endurance events scheduled this winter including: -- TriRock San Diego - September 21 -- IRONMAN Chattanooga - September 28 -- Chicago Marathon - October 14 (limited entries) -- New York Marathon - November 1 (limited entries) --...

2014-07-22 08:32:06

New product offers treatment to significant unmet medical need in supportive cancer care DALLAS and NEW YORK, July 22, 2014 /PRNewswire/ -- ACCESS PHARMACEUTICALS, INC. (OTCBB: ACCP), a developer of new products for oncology supportive care, announced today that it has received 510(K) marketing clearance from the U.S. Food and Drug Administration (FDA) for ProctiGard(TM), its novel treatment for symptomatic management of rectal mucositis. The Company indicated its development of...

2014-07-21 12:24:51

DANVERS, Mass., July 21, 2014 /PRNewswire/ -- The Scleroderma Foundation is preparing for 600 people from around the world to attend its National Patient Education Conference later this week in Southern California. This unique educational event will be held at the Anaheim Marriot Friday, July 25, through Sunday, July 27. The conference focuses on scleroderma, a mysterious, and sometimes fatal, autoimmune disease that causes a person's body to attack itself by creating too much...

2014-07-18 23:02:00

Annual conference provides groundbreaking approaches to treating patients with interrelated autoimmune conditions. Malvern, PA (PRWEB) July 18, 2014 The inaugural Interdisciplinary Autoimmune Summit (IAS) brought together more than 150 gastroenterologists, rheumatologists, dermatologists, immunologists, internists, industry, and other allied healthcare professionals at The Mirage, Las Vegas, NV, June 20-22, 2014. "IAS 2014 was a wonderful opportunity to meet and discuss best...

2014-07-18 08:25:11

Take Steps Walk Program Helps Fund Key Initiatives for CCFA NEW YORK, July 18, 2014 /PRNewswire-USNewswire/ -- High-powered research teams supported by the Crohn's & Colitis Foundation of America (CCFA) are gearing up for an ambitious new goal: developing individualized treatment approaches for patients with Crohn's disease and ulcerative colitis (UC), also known as inflammatory bowel diseases (IBD), through their Genetics and Microbiome Research Initiatives. It's fundraising...

2014-07-16 20:22:34

Local New York team is forming to prepare runners and walkers for the ultimate tour of Vegas NEW YORK, July 16, 2014 /PRNewswire/ -- The 6th annual Rock 'n 'Roll Las Vegas Marathon & 1/2 Marathon to benefit the Crohn's & Colitis Foundation of America (CCFA) is taking place on Sunday, November 16, 2014. "Team Challenge prepares participants to run or walk a half marathon while helping to raise necessary funds for research, education, and support for the 1.4 million Americans suffering...


Word of the Day
drawcansir
  • A blustering, bullying fellow; a pot-valiant braggart; a bully.
This word is named for Draw-Can-Sir, a character in George Villiers' 17th century play The Rehearsal.
Related